OSR Health (OSRHW) Return on Invested Capital (2025 - 2026)
OSR Health (OSRHW) posted Return on Invested Capital of 0.03% for Q1 2026, up 5.57% sequentially from 0.04% in Q4 2025.
OSR Health (OSRHW) Return on Invested Capital (2025 - 2026) Analysis & Trends
OSR Health has reported Return on Invested Capital for 2 years, with the latest figure at 0.03% in Q1 2026.
- Quarterly Return on Invested Capital changed N/A year-over-year to 0.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03% (changed N/A YoY) and the FY2025 annual result came in at 0.08%, changed N/A from the prior year.
- Return on Invested Capital improved to 0.03% in Q1 2026 per OSRHW's latest filing, from 0.04% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.03% in Q3 2025 and troughed at 0.04% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 0.00% |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | -0.35% |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03% |
| Dec 31, 2025 | -0.04% |
| Sep 30, 2025 | -0.03% |